Lunai Bioworks (LNAI) Current Leases (2019 - 2026)
Lunai Bioworks (LNAI) posted quarterly Current Leases of $288390.0 for Q1 2026, down 47.34% year-over-year from $547683.0 in Q1 2025, and up 4.88% quarter-over-quarter from $274983.0 in Q4 2025.
Lunai Bioworks (LNAI) Current Leases (2019 - 2026) Analysis & Trends
Lunai Bioworks' Current Leases history runs 8 years deep, the most recent figure standing at $288390.0 for Q1 2026.
- In Q1 2026, Current Leases fell 47.34% year-over-year to $288390.0; the TTM figure through Mar 2026 stood at $288390.0 (down 47.34% YoY), while the FY2025 annual figure was $313047.0, down 36.57% from the prior year.
- Current Leases for Q1 2026 stood at $288390.0, up from $274983.0 in the prior quarter.
- The five-year high for Current Leases was $562287.0 in Q4 2024, with the low at $193422.0 in Q2 2023.
- The 5-year median for Current Leases is $277775.0 (2025), against an average of $324130.1.
- The sharpest annual moves came in 2024 and 2025: Current Leases soared 157.83% in 2024, then sank 51.1% in 2025.
- Lunai Bioworks' Current Leases stood at $202370.0 in 2022, then gained by 7.77% to $218085.0 in 2023, then jumped by 157.83% to $562287.0 in 2024, then tumbled by 51.1% to $274983.0 in 2025, then rose by 4.88% to $288390.0 in 2026.
- Business Quant data shows LNAI's Current Leases at $288390.0 in Q1 2026, $274983.0 in Q4 2025, and $277775.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Lunai Bioworks | 6.94 Mn | 3.78 Mn | 20,942.00 | 288,390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,390.00 |
| Dec 31, 2025 | 274,983.00 |
| Sep 30, 2025 | 277,775.00 |
| Jun 30, 2025 | 313,047.00 |
| Mar 31, 2025 | 547,683.00 |
| Dec 31, 2024 | 562,287.00 |
| Sep 30, 2024 | 504,254.00 |
| Jun 30, 2024 | 493,553.00 |
| Mar 31, 2024 | 483,226.00 |
| Dec 31, 2023 | 218,085.00 |
| Sep 30, 2023 | 214,061.00 |
| Jun 30, 2023 | 193,422.00 |
| Mar 31, 2023 | 206,222.00 |
| Dec 31, 2022 | 202,370.00 |
| Sep 30, 2022 | 198,557.00 |
| Jun 30, 2022 | 253,636.00 |
| Mar 31, 2022 | 278,661.00 |
| Dec 31, 2021 | 303,488.00 |
| Sep 30, 2021 | 297,896.00 |
| Jun 30, 2021 | 292,409.00 |